Patients who underwent left atrial appendage closure with a next-generation device were significantly less likely to experience in-hospital major adverse events, including pericardial effusion ...

SOLO-CLOSE demonstrated high success and safety with reduced complexity, offering a promising streamlined option for left ...

Women who underwent left atrial appendage occlusion for nonvalvular atrial fibrillation experienced more adverse in-hospital outcomes and longer hospital stays compared with men, according to data ...

A 62-year-old woman was evaluated for recurrent hemorrhagic pericardial effusion. Fourteen years earlier, she had undergone transcatheter closure of an atrial septal defect. A diagnosis was made.

Anatomical differences are one, and women in this study had a smaller LAA maximal width. “However, other characteristics, such as left atrial size, LAA morphology, and number of device deployment ...

SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency after percutaneous LAA ...

Left atrial appendage closure is a minimally invasive ... Predischarge imaging should be performed with 2-dimensional transthoracic echocardiography to rule out pericardial effusion and ...

(UPDATED) In patients undergoing left atrial appendage (LAA) occlusion, the Amplatzer Amulet device (Abbott) provides better closure as well as noninferior safety and effectiveness compared with the ...

The researchers reported that post-op pericardial effusion was lower in the left pericardiotomy group at 12% versus 21% in the no-intervention group (RR 0.58, 95% CI 0.37-0.91).

Surgical occlusion of the left atrial appendage has been hypothesized to prevent ischemic stroke in patients with atrial fibrillation, but this has not been proved. The procedure can be performed d ...